Release Date: 12/10/09 16:13 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 725.45KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%